Indira IVF integrates diagnostics services with special focus on women & child care

20 December 2022 | News

Forays into diagnostics business with Indira PathLabs

image credit- shutterstock

image credit- shutterstock

Indira IVF has announced its entry into diagnostics by offering pathology tests uniquely catering to the needs of women and child. The organisation has inaugurated its state-of-the-art laboratories in Lucknow, New Delhi, Patna and Mumbai, and aims to launch a total of 30+ pathology laboratories in strategic geographies by FY24 and two super speciality labs in Mumbai and Delhi.

Indira PathLabs will leverage Indira IVF’s already established network of 114 centres in the country. In the Phase 1 of expansion in FY23, it will gradually expand services to all major geographies where it has a robust presence including Lucknow, Patna, New Delhi, Mumbai, Pune, Udaipur, Jaipur, Varanasi, Kolkata, Ranchi, Bhubaneswar, and Bengaluru to name a few.

The company aspires to launch its pathology offerings by way of fully-equipped, independent laboratories and harnessing the benefits of automation.

Backed by an array of trusted clinical offerings, Indira PathLabs will provide accessible, high-quality diagnostics services and hopes to bridge the existing gaps in the market specifically related to conception and the needs of women and their child. The organisation aspires to incorporate more than 1000 tests to fully encompass the gamut of diagnostic investigations required on the journey of conception and leading to a healthy child’s birth.

Dr Nitiz Murdia – Managing Director & Co-Founder of Indira IVF said, “Genetic testing is an essential tool to ascertain the future child’s health and check for the presence of any genetic anomalies. In this regard, in addition to our pathology services, we also seek to introduce two genetic testing laboratories in the country that can perform highly specialised tests required for the prediction of such genetic anomalies in the child conceived."

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account